Author Correction: Intravenous and intracranial GD2-CAR T cells for H3K27M ⁺ diffuse midline gliomas.

Autor: Monje M; Department of Neurology and Neurological Sciences, Stanford University, Stanford, CA, USA. mmonje@stanford.edu.; Division of Pediatric Hematology/Oncology/Stem Cell Transplant and Regenerative Medicine, Department of Pediatrics, Stanford University, Stanford, CA, USA. mmonje@stanford.edu.; Stanford Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University, Stanford, CA, USA. mmonje@stanford.edu.; Department of Neurosurgery, Stanford University, Stanford, CA, USA. mmonje@stanford.edu.; Department of Pathology, Stanford University, Stanford, CA, USA. mmonje@stanford.edu.; Howard Hughes Medical Institute, Stanford University, Stanford, CA, USA. mmonje@stanford.edu., Mahdi J; Department of Neurology and Neurological Sciences, Stanford University, Stanford, CA, USA.; Stanford Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University, Stanford, CA, USA., Majzner R; Division of Pediatric Hematology/Oncology/Stem Cell Transplant and Regenerative Medicine, Department of Pediatrics, Stanford University, Stanford, CA, USA.; Stanford Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University, Stanford, CA, USA., Yeom KW; Department of Neurology and Neurological Sciences, Stanford University, Stanford, CA, USA.; Department of Neurosurgery, Stanford University, Stanford, CA, USA.; Division of Neuroradiology, Department of Radiology, Stanford University, Stanford, CA, USA., Schultz LM; Division of Pediatric Hematology/Oncology/Stem Cell Transplant and Regenerative Medicine, Department of Pediatrics, Stanford University, Stanford, CA, USA.; Stanford Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University, Stanford, CA, USA., Richards RM; Division of Pediatric Hematology/Oncology/Stem Cell Transplant and Regenerative Medicine, Department of Pediatrics, Stanford University, Stanford, CA, USA.; Stanford Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University, Stanford, CA, USA., Barsan V; Division of Pediatric Hematology/Oncology/Stem Cell Transplant and Regenerative Medicine, Department of Pediatrics, Stanford University, Stanford, CA, USA.; Stanford Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University, Stanford, CA, USA., Song KW; Department of Neurology and Neurological Sciences, Stanford University, Stanford, CA, USA.; Stanford Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University, Stanford, CA, USA., Kamens J; Division of Pediatric Hematology/Oncology/Stem Cell Transplant and Regenerative Medicine, Department of Pediatrics, Stanford University, Stanford, CA, USA.; Stanford Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University, Stanford, CA, USA., Baggott C; Stanford Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University, Stanford, CA, USA., Kunicki M; Stanford Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University, Stanford, CA, USA., Rietberg SP; Stanford Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University, Stanford, CA, USA., Lim AS; Stanford Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University, Stanford, CA, USA., Reschke A; Division of Pediatric Hematology/Oncology/Stem Cell Transplant and Regenerative Medicine, Department of Pediatrics, Stanford University, Stanford, CA, USA.; Stanford Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University, Stanford, CA, USA., Mavroukakis S; Stanford Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University, Stanford, CA, USA., Egeler E; Stanford Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University, Stanford, CA, USA., Moon J; Stanford Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University, Stanford, CA, USA., Patel S; Stanford Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University, Stanford, CA, USA., Chinnasamy H; Stanford Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University, Stanford, CA, USA., Erickson C; Stanford Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University, Stanford, CA, USA., Jacobs A; Stanford Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University, Stanford, CA, USA., Duh AK; Department of Neurosurgery, Stanford University, Stanford, CA, USA., Tunuguntla R; Stanford Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University, Stanford, CA, USA., Klysz DD; Stanford Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University, Stanford, CA, USA., Fowler C; Stanford Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University, Stanford, CA, USA., Green S; Division of Pediatric Hematology/Oncology/Stem Cell Transplant and Regenerative Medicine, Department of Pediatrics, Stanford University, Stanford, CA, USA., Beebe B; Stanford Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University, Stanford, CA, USA., Carr C; Stanford Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University, Stanford, CA, USA., Fujimoto M; Stanford Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University, Stanford, CA, USA., Brown AK; Stanford Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University, Stanford, CA, USA., Petersen AG; Stanford Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University, Stanford, CA, USA., McIntyre C; Cellular Therapy Facility, Stanford Health Care, Palo Alto, CA, USA., Siddiqui A; Cellular Therapy Facility, Stanford Health Care, Palo Alto, CA, USA., Lepori-Bui N; Cellular Therapy Facility, Stanford Health Care, Palo Alto, CA, USA., Villar K; Cellular Therapy Facility, Stanford Health Care, Palo Alto, CA, USA., Pham K; Cellular Therapy Facility, Stanford Health Care, Palo Alto, CA, USA., Bove R; Cellular Therapy Facility, Stanford Health Care, Palo Alto, CA, USA., Musa E; Cellular Therapy Facility, Stanford Health Care, Palo Alto, CA, USA., Reynolds WD; Stanford Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University, Stanford, CA, USA., Kuo A; Stanford Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University, Stanford, CA, USA., Prabhu S; Stanford Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University, Stanford, CA, USA., Rasmussen L; Department of Pediatrics, Division of Pediatric Critical Care Medicine, Stanford University, Stanford, CA, US., Cornell TT; Department of Pediatrics, Division of Pediatric Critical Care Medicine, Stanford University, Stanford, CA, US., Partap S; Department of Neurology and Neurological Sciences, Stanford University, Stanford, CA, USA., Fisher PG; Department of Neurology and Neurological Sciences, Stanford University, Stanford, CA, USA., Campen CJ; Department of Neurology and Neurological Sciences, Stanford University, Stanford, CA, USA., Grant G; Department of Neurosurgery, Stanford University, Stanford, CA, USA., Prolo L; Department of Neurosurgery, Stanford University, Stanford, CA, USA., Ye X; Department of Neurosurgery, Johns Hopkins School of Medicine, Baltimore, MD, USA., Sahaf B; Stanford Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University, Stanford, CA, USA., Davis KL; Division of Pediatric Hematology/Oncology/Stem Cell Transplant and Regenerative Medicine, Department of Pediatrics, Stanford University, Stanford, CA, USA.; Stanford Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University, Stanford, CA, USA., Feldman SA; Stanford Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University, Stanford, CA, USA., Ramakrishna S; Division of Pediatric Hematology/Oncology/Stem Cell Transplant and Regenerative Medicine, Department of Pediatrics, Stanford University, Stanford, CA, USA. ramakrs@stanford.edu.; Stanford Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University, Stanford, CA, USA. ramakrs@stanford.edu., Mackall C; Division of Pediatric Hematology/Oncology/Stem Cell Transplant and Regenerative Medicine, Department of Pediatrics, Stanford University, Stanford, CA, USA. cmackall@stanford.edu.; Stanford Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University, Stanford, CA, USA. cmackall@stanford.edu.; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA. cmackall@stanford.edu.; Division of Stem Cell Transplantation and Cell Therapy, Department of Medicine, Stanford University, Stanford, CA, USA. cmackall@stanford.edu.

Publikováno v: Nature [Nature] 2024 Nov 29. Date of Electronic Publication: 2024 Nov 29.

A phase 1 clinical trial of NKTR-255 with CD19-22 CAR T-cell therapy for refractory B-cell acute lymphoblastic leukemia.

Autor: Srinagesh H; Division of Hematology, Stanford University, Stanford, CA., Jackson C; Division of Hematology/Oncology, UT Southwestern, Dallas, TX., Shiraz P; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University, Stanford, CA., Jeyakumar N; Division of Hematology, Stanford University, Stanford, CA., Hamilton M; Division of Hematology, Stanford University, Stanford, CA., Egeler E; Center for Cancer Cell Therapy, Stanford University, Stanford, CA., Mavroukakis S; Center for Cancer Cell Therapy, Stanford University, Stanford, CA., Kuo A; Center for Cancer Cell Therapy, Stanford University, Stanford, CA., Cancilla J; Center for Cancer Cell Therapy, Stanford University, Stanford, CA., Sahaf B; Center for Cancer Cell Therapy, Stanford University, Stanford, CA., Agarwal N; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University, Stanford, CA., Kanegai A; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University, Stanford, CA., Kramer AM; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University, Stanford, CA.; Center for Cancer Cell Therapy, Stanford University, Stanford, CA., Arai S; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University, Stanford, CA., Bharadwaj S; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University, Stanford, CA., Dahiya S; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University, Stanford, CA., Hosoya H; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University, Stanford, CA., Johnston L; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University, Stanford, CA., Kennedy V; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University, Stanford, CA., Liedtke M; Division of Hematology, Stanford University, Stanford, CA., Lowsky R; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University, Stanford, CA., Mikkilineni L; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University, Stanford, CA., Negrin R; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University, Stanford, CA., Rezvani A; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University, Stanford, CA., Sidana S; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University, Stanford, CA., Shizuru J; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University, Stanford, CA., Smith M; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University, Stanford, CA., Weng WK; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University, Stanford, CA., Feldman S; Center for Cancer Cell Therapy, Stanford University, Stanford, CA., Frank MJ; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University, Stanford, CA.; Center for Cancer Cell Therapy, Stanford University, Stanford, CA., Lee Z; Nektar Therapeutics, San Francisco, CA., Tagliaferri M; Nektar Therapeutics, San Francisco, CA., Marcondes AM; Nektar Therapeutics, San Francisco, CA., Miklos D; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University, Stanford, CA.; Center for Cancer Cell Therapy, Stanford University, Stanford, CA., Mackall C; Center for Cancer Cell Therapy, Stanford University, Stanford, CA., Muffly L; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University, Stanford, CA.; Center for Cancer Cell Therapy, Stanford University, Stanford, CA.

Publikováno v: Blood [Blood] 2024 Oct 17; Vol. 144 (16), pp. 1689-1698.

Sequential intravenous and intracerebroventricular GD2-CAR T-cell therapy for H3K27M-mutated diffuse midline gliomas.

Autor: Monje M, Mahdi J, Majzner R, Yeom K, Schultz LM, Richards RM, Barsan V, Song KW, Kamens J, Baggott C, Kunicki M, Lim AS, Reschke A, Mavroukakis S, Egeler E, Moon J, Patel S, Chinnasamy H, Erickson C, Jacobs A, Duh AK, Rietberg SP, Tunuguntla R, Klysz DD, Fowler C, Green S, Beebe B, Carr C, Fujimoto M, Brown AK, Petersen AG, McIntyre C, Siddiqui A, Lepori-Bui N, Villar K, Pham K, Bove R, Musa E, Reynolds W, Kuo A, Prabhu S, Rasmussen L, Cornell TT, Partap S, Fisher PG, Campen CJ, Grant G, Prolo L, Ye X, Sahaf B, Davis KL, Feldman SA, Ramakrishna S, Mackall C

Publikováno v: MedRxiv : the preprint server for health sciences [medRxiv] 2024 Jun 27. Date of Electronic Publication: 2024 Jun 27.

HLH-like toxicities predict poor survival after the use of tisagenlecleucel in children and young adults with B-ALL.

Autor: McNerney KO; Cancer and Blood Disorders Institute, Johns Hopkins All Children's Hospital, St. Petersburg, FL.; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD., Si Lim SJ; Division of Oncology, Department of Pediatrics, John A. Burns School of Medicine, University of Hawai'i at Manoa, Honolulu, HI., Ishikawa K; Department of Quantitative Health Sciences, John A. Burns School of Medicine, University of Hawai'i at Manoa, Honolulu, HI., Dreyzin A; Center for Cancer and Blood Disorders, Children's National Hospital, Washington, DC., Vatsayan A; Center for Cancer and Blood Disorders, Children's National Hospital, Washington, DC., Chen JJ; Department of Quantitative Health Sciences, John A. Burns School of Medicine, University of Hawai'i at Manoa, Honolulu, HI., Baggott C; Department of Pediatrics, School of Medicine, Stanford University, Stanford, CA., Prabhu S; Center for Cancer Cell Therapy, Stanford Cancer Institute, School of Medicine, Stanford University, Stanford, CA., Pacenta HL; Department of Pediatrics, University of Texas Southwestern Medical Center/Children's Health, Dallas, TX.; Division of Hematology and Oncology, Cook Children's Medical Center, Fort Worth, TX., Philips C; Division of Pediatrics, University of Cincinnati, Cincinnati, OH.; Cincinnati Children's Hospital Medical Center, Cancer and Blood Disease Institute, Cincinnati, OH., Rossoff J; Division of Pediatric Hematology, Oncology, and Stem Cell Transplantation, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL., Stefanski HE; National Marrow Donor Program/Be the Match, Minneapolis, MN., Talano JA; Division of Hematology/Oncology/Blood and Marrow Transplantation, Department of Pediatrics, Medical College of Wisconsin and Children's Wisconsin, Milwaukee, WI., Moskop A; Division of Hematology/Oncology/Blood and Marrow Transplantation, Department of Pediatrics, Medical College of Wisconsin and Children's Wisconsin, Milwaukee, WI., Verneris M; University of Colorado School of Medicine, Children's Hospital of Colorado, Aurora, CO., Myers D; Department of Hematology, Oncology and Blood and Marrow Transplantation, Children's Mercy Hospital, University of Missouri Kansas City, Kansas City, MO., Karras NA; Department of Pediatrics, City of Hope National Medical Center, Duarte, CA., Brown P; Department of Oncology, Sidney Kimmel Cancer Center, John Hopkins University School of Medicine, Baltimore, MD., Bonifant CL; Department of Oncology, Sidney Kimmel Cancer Center, John Hopkins University School of Medicine, Baltimore, MD., Qayed M; Division of Pediatric Hematology/Oncology and Bone Marrow Transplantation, Aflac Cancer and Blood Disorders Center, Emory University and Children's Healthcare of Atlanta, Atlanta, GA., Hermiston M; University of California San Francisco Benioff Children's Hospital, San Francisco, CA., Satwani P; Division of Pediatric Hematology, Oncology and Stem Cell Transplant, Department of Pediatrics, Columbia University Medical Center, New York, NY., Krupski C; Division of Pediatrics, University of Cincinnati, Cincinnati, OH.; Cincinnati Children's Hospital Medical Center, Cancer and Blood Disease Institute, Cincinnati, OH., Keating AK; University of Colorado School of Medicine, Children's Hospital of Colorado, Aurora, CO., Baumeister SHC; Division of Pediatric Hematology-Oncology, Boston Children's Hospital, Boston, MA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA.; Department of Pediatrics, Harvard Medical School, Boston, MA., Fabrizio VA; University of Colorado School of Medicine, Children's Hospital of Colorado, Aurora, CO., Chinnabhandar V; Division of Pediatric Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota Medical School, Minneapolis, MN., Egeler E; Center for Cancer Cell Therapy, Stanford Cancer Institute, School of Medicine, Stanford University, Stanford, CA., Mavroukakis S; Center for Cancer Cell Therapy, Stanford Cancer Institute, School of Medicine, Stanford University, Stanford, CA., Curran KJ; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Pediatrics, Weill Cornell Medical College, Cornell University, New York, NY., Mackall CL; Department of Pediatrics, School of Medicine, Stanford University, Stanford, CA.; Center for Cancer Cell Therapy, Stanford Cancer Institute, School of Medicine, Stanford University, Stanford, CA.; Department of Medicine, School of Medicine, Stanford University, Stanford, CA., Laetsch TW; Department of Pediatrics and Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.; Division of Oncology, Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA., Schultz LM; Department of Pediatrics, School of Medicine, Stanford University, Stanford, CA.

Publikováno v: Blood advances [Blood Adv] 2023 Jun 27; Vol. 7 (12), pp. 2758-2771.

1004 - Regulatory Affairs, Quality Systems, Policy, and Ethics: INVESTIGATING PARTICULATES IN CELLULAR THERAPY PRODUCTS

Autor: Tutt, T., Pham, T., Brown, A., Chinnasamy, H., Feldman, S., Egeler, E., Patel, S., Majzner, R., Mackall, C., Monje, M., McLeod, M.G., Lepori-Bui, N., Villar, K., Siddiqui, A., Diaz, N., Sukle, N., McIntyre, C., Meyer, E.

Publikováno v: In Cytotherapy May 2022 24(5) Supplement:S189-S190